chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient mentioned swelling/redness/itching/pain for a day following administration (10/21/17).  Upon notifying the pharmacy (10/23/17), she just had swelling and redness around the deltoid region of right arm.  Counseled patient to use cold compress and NSAIDs to relief and to contact primary doctor if symptoms worsen.
This spontaneous report was received from a medical assistant referring to an unspecified patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication were not provided. On an unknown date, the patient may have received improperly stored M-M-R II injection (lot # L032182, expiration date 25-AUG-2017) for (strength, dose and route were unknown), VAQTA injection (lot # M011116, expiration date 17-JUN-2017) (strength, dose and route were unknown), RECOMBIVAX HB injection (lot # M000442, expiration date 31-MAR-2018) (strength, dose and route were unknown), GARDASIL 9 injection (lot # M013636, expiration date 15-FEB-2018) (strength, dose and route were unknown), PNEUMOVAX 23 injection (lot # L048265, expiration date 10-JUN-2017) (strength, dose and route were unknown) or ROTATEQ Oral liquid (orally, lot # M031802, expiration date 09-NOV-2017) (strength and dose were unknown); all of them for prophylaxis. On an unknown date, the vaccines were exposed to a temperature excursion between 46 Farenheit degrees and 77 Farenheit degrees for 3 hours and 45 minutes. There was no previous temperature excursion. Digital Data Logger was involved. The medical assistant reported she was not sure whether the patient received the vaccine. No adverse effect were reported. Additional information has been requested.
Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Hypertension-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Unable to Sleep-Medium, Additional Details: pt state went to ER twice will follow up with her dr
Palpitations very frequent resulting in highly irregular rhythm. Periods of in and out of  V-tach with runs of  PVCs >36, and trigeminy. Associated SOB and chest tightness. Persistent for >48hrs<72hrs. Palpitations continued 1-2per min for the wk following vaccination then became less frequent .  26wks pregnant at time of vaccination. Due date 4/26/21
The patient was diagnosed with acute hepatitis B approximately five weeks after the vaccination. She started feeling poorly - achiness, lassitude, etc - approximately 2 weeks after the vaccine.
chills, vomiting,fever,dark urine. Went to clinic and was given rx for nausua after 1st vaccine. After 2nd vaccine went to Doctor and had a series of blood tests and ct scan. Symptoms subsided after a few days, dark urine for a couple of weeks. Tests showed: ast(sgot) 90 , alt (sgpt) 210
Patient came in today to receive his second dose of his COVID-19 shot on 6APR2021 patient originally received his first dose on 16MAR2021. when staff went to document his second dose the program system would not allow, when staff looked into his record it showed he received a dose 5APR2021, staff checked the schedule for 5APR2021 and the patient self scheduled for a "First Dose" on 5APR2021. Patient at this time already left the building staff then informed provider who then contacted the nurse educator to ask about any potential side effects. staff attempted to contact patient multiple times with no answer. during this time, more providers were informed of the incident, Patient finally called back and spoke with the provider, provider stated the patient confirmed he scheduled his 5APR2021 on purpose so he can get his second, first dose. he came in today to receive his original second dose that was scheduled 21 days after receiving his original first dose on 16MAR2021. patient stated he knew he received 3 doses and lied about this being his first shot, patient was  asked multiple times on 5APR2021 if this was his first shot, and continued to receive his dose. provider informed patient that at this moment there is not enough information on receiving 3 vaccines and  if he experiences any extreme adverse effects to go to the ED right away. patient stated he understands and does not want to get checked due to him having major plans this week and if anything happens he will call his PCM.
At around 6:30 p.m on April 9, 2021, I started to feel very cold at home. I had sever chills where I was under 5 heavy blankets unable to get warm. I also had a high fever which was 104.8 degrees Fahrenheit. I also threw up twice and had body aches in my arm where the nurse injected the vaccine, my lower back, and calves of my legs. When my temperature did not go down, I went to Emergency Room at around 12:00 a.m. April 10, 2021. I was placed in isolation. The nurse took my vitals and the doctor ordered covid test for me and a urine analysis. The covid test came back negative and my urine analysis was in the normal range. The nurse gave me Tynenol at  around 1 am and ibuprofen at around 2:30 am. I was discharged at approximately 5 am on April 10, 2021 with a 98.4 degree temperature.
I noticed on January 12 that my left arm where I received the shot my bones were aching and my joints (my shoulder, my elbow, my forearm bones, and all my hand joints) were aching and my hand was slightly swollen. My coworker reported aching joints two days after she received the vaccine. So I?m not sure if my aching joints are related to the vaccine but I?m suspicious they are.
fever; light-headedness; unable to walk; chills; This is a spontaneous report from a contactable consumer (patient) from Pfizer-sponsored program Pfizer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) dose 1 for covid-19 immunization. The patient experienced fever, light-headedness, unable to walk, chills on an unspecified date. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Approximately 36 hours following vaccine, I experienced a hypomanic episode lasting about 6 hours. My bipolar II disorder has been successfully regulated for more than 10 years, with rare depressive breakthrough. My last manic episode was 36 hours after my first Shingrix dose, 3/9/23. Prior to that, my previous manic phase was more than 5 years ago. I notified both the pharmacist and my psychiatrist. Because the episode resolved in less than 24 hours, no further medical intervention was required.
This spontaneous report as received from a pharmacist refers to a 17-year-old patient of unknown gender. No concurrent conditions or medical history were provided. On 09-JUL-2016, the patient was vaccinated with an adult (1 mL) dose of VAQTA 50/1.0 U/ml injection (lot# reported as M01365, expiry date: 26-MAY-2017; route and site of administration were unspecified). No concomitant medications were reported. Additional information has been requested.
pain at the injection site; fever; chills last night; This is a spontaneous report from a contactable healthcare professional. A male patient of an unspecified age started to receive bnt162b2 (BNT162B2), via an unspecified route of administration from 06Jan2021 to 06Jan2021 at a single dose for an unspecified indication. The patient's patient medical history and concomitant medications were not reported. It was reported that the patient had reported pain at the injection site, fever and chills last night on 06Jan2021 and feels better today. The outcome of the events was recovering.
This spontaneous report as received from a nurse refers to an unspecified patients of unknown age and gender. The patient pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patients were vaccinated with PROQUAD (Merck) (dosing details were not reported) lot # L045678 expiry date 09-MAR-2017 which was exposed to a temperature of 6.1 degrees F for a time frame of 3 hours, no previous temperature excursion was reported (incorrect product storage). No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint involved. This is one of the two reports received from the same reporter. Additional information has been requested.
a bit more stiffness and achiness in my knees/ regained some severity after the second; a bit more stiffness and achiness in my knees/ regained some severity after the second; This is a spontaneous report from a contactable consumer reported that. A 61-years-old female patient received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 2 via an unspecified route of administration on 23Mar2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization(Age at vaccination 61 years). The patient past medical history included breast cancer from an unknown date and unknown if ongoing three years ago. The patient's concomitant medications were not reported.  Since getting her first shot on March 4, patient have noticed an increase in foot spasms and discomfort in her feet concurrent with an improvement in sensation in her arches. She also had several instances of a brief, very mild tremor in my right index finger, which was where most of the residual neuropathy in her hand resides; when the neuropathy was more pronounced, that finger underwent stronger and more pronounced tremors, whereas what patient had this month is negligible. Patient also had a bit more stiffness and achiness in her knees (both of which have recovered from traumatic injuries), which had mostly leveled off before my second shot but then regained some severity after the second, which was on March 23 ("Yes, a 19-day cycle my shots were administered by Hospital"). It was unknown that patient was tested for COVID-19 after the vaccination or not. It was unknown if the patient received any treatment for the reported adverse event or not. The outcome of the events was unknown.  No follow up attempts are possible. Information about lot/batch number cannot be obtained
This case was reported by a pharmacist and described the occurrence of localized pain in a 15-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). On 9 August 2011 at 15:45 the subject received a dose of BOOSTRIX at 0.5 ml in the left arm. On 9 August 2011, 6 hours after vaccination with BOOSTRIX, the subject experienced localized pain and local swelling. It was also reported that the dose of BOOSTRIX administered was an extra dose as the subject had received a vaccination of tdap (unspecified) 2 years earlier. Two days later, on 11 August 2011, the subject had considerable improvement of localized pain and swelling, but had developed a sore throat. Localized pain and swelling were considered to be probably related to BOOSTRIX. Sore throat was unrelated with outcome unknown.
She had a stiff body, looked weird and purple just like the previous episode in July 2018. She had a stare and the whole episode lasted for about 3-4 minutes. 911 was called and she was taken to ER and evaluated. CBC, Metabolic profile was done. She was referred to a neurologist and he admitted her at Hospital and a Video EEG was done. It was interpreted as a normal EEG. Seizure diagnosis was considered.
Itchiness, swelling, redness, and mild pain occurring at injection site 7 days after vaccination. Lesion is approximately 3 inches in diameter and warm to the touch.
Received 6 months immunization DTaP, flu, hib, PREVNAR, ROTATEQ and hepatatis B.
One week after the second shot I started to get bumps on my neck, that was on a Friday night.  By Sunday it was much worse so I went to the emergency care facility and the Dr. told me I had shingles and prescribed  Valacyclovir for 7 days.  I reached out to people on an App and explained my side effect.  There were over 9 people that also had the shingles after the second dose.  They didn't necessarily get the shot from the same pharmacy.   It is obvious that there is a direct correlation between the two.
This spontaneous report was received from a physician via company representative and refers to a 12-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with first dose of GARDASIL (dose, route and site of administration, lot # and expiration date were not reported) for prophylaxis. The patient did not come for her second dose of GARDASIL because a couple months after first vaccination reported as ''3 or 4 years ago'', the patient felt that her vision was tricking her. It was also reported as ''when you look at your iPad and you need to move the screen from upside down to rightside up she would had to screen rightside up and she would feel it was upside down''. At that time the physician referred her to a neurologist but the neurologist could not find anything wrong with the girl. The event resolved on its own on unknown date reported as ''couple months later''. It was unknown if the patient was seeking medical attention. The causality assessment between the event and GARDASIL was not provided.
PATIENT DESCRIBED THE APPEARANCE OF ROUND, RED LESIONS ON TRUNK, LEFT AND RIGHT ARM OF BODY.
The day after the vaccine I noticed that I could not open my mouth wide. when I do open my mouth wide it makes a very loud popping sound. There is no pain though.
Patient's mother called to say her daughter's throat swelled and she broke out in hives 3 hours after administration of meningitis vaccine and Td vaccine.
This case was reported by a consumer and described the occurrence of fever in a 13-month-old female subject who was vaccinated with PEDIARIX. A physician or other health care professional has not verified this report. On  unspecified dates, the subject received the 1st dose, 2nd dose, 3rd dose and 4th doses of PEDIARIX. On unspecified dates, the subject's mother reported that her daughter received the 1st dose of PEDIARIX at 2 months old; the 2nd dose of PEDIARIX at 4 months old; the 3rd dose of PEDIARIX at 6 months old; and the 4th dose of PEDIARIX at 13 months old. At unspecified times following all four doses of PEDIARIX, the subject experienced a fever. An extra (4th) dose of PEDIARIX was inadvertently administered to the subject instead of an intended DTAP vaccine. At the time reporting, the fever was unresolved. The subject's mother refused to provide any further details, as she wanted to leave it up to the physician's office to provide this information. This case is lost to follow-up, as the reporter did not provide any contact information.
My ears began ringing about 24 hours after I received the first dose of the Pfizer vaccination. It has been ongoing since and it's been a half hour now.
soreness in arm; redness at the site of injection; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of the second episode of PAIN IN EXTREMITY (soreness in arm), the first episode of PAIN IN EXTREMITY (soreness in arm) and VACCINATION SITE ERYTHEMA (redness at the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced the first episode of PAIN IN EXTREMITY (soreness in arm). On 21-Apr-2021, the patient experienced the second episode of PAIN IN EXTREMITY (soreness in arm) and VACCINATION SITE ERYTHEMA (redness at the site of injection). At the time of the report, last episode of PAIN IN EXTREMITY (soreness in arm) and VACCINATION SITE ERYTHEMA (redness at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided Treatment information was not provided
Lethargic; Cold; Chills; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), NASOPHARYNGITIS (Cold), CHILLS (Chills) and PAIN IN EXTREMITY (Arm soreness) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concomitant products included levogestroeol and VITAMIN 15 for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced LETHARGY (Lethargic), NASOPHARYNGITIS (Cold), CHILLS (Chills) and PAIN IN EXTREMITY (Arm soreness). At the time of the report, LETHARGY (Lethargic), NASOPHARYNGITIS (Cold), CHILLS (Chills) and PAIN IN EXTREMITY (Arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications not reported.  Treatment information not reported.   This case was linked to MOD-2021-076278 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow up received on 15-APR-2021. Name correction/third dose.; Sender's Comments:  MOD-2021-076278:2nd dose
Left leg significantly swollen from hip to knee.  Pt complained of pain and refusing to bear weight on leg.  Mild splotchy erythema about 2cm.
Breathing problem & rash & red area on arm 2 1/4 x 1 1/4 in deltoid reported by school nurse lasted several hours.
Chills, fever, vomiting, diarrhea, achy joints and muscles, stomach pain, swollen roof of mouth and gums, headache.  02/02/2015. Arm swollen and red at injection site with itchy rash. 02/09/2015 Stools green had not eaten anything green for over week.
pain w/movement 18 hrs post inject; @ 24 hrs post inject-pain w/movement, localized skin, rash, warmth @ site, arthralgia (hip, knee, ankle, shoulder joints), low grade fever; @ 48 hrs pain w/movement, localized rash, warmth;
tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable nurse (patient) from a Pfizer-sponsored program Pfizer First Connect. A 55-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), via an unspecified route of administration in the right arm on 18Dec2020 at single dose for covid 19 immunisation as healthcare professional and husband was high risk. Medical history included hypertension from 2019 and ongoing. Concomitant medication included amlodipine besilate (NORVASC, 5 mg) from 2019 and ongoing for high blood pressure. The patient experienced tested positive for covid-19 on 03Jan2021 with outcome of not recovered, congestion and headache in Jan2021 with outcome of unknown. The patient underwent lab tests and procedures which included COVID test on 03Jan2021 and the results came back positive on 04Jan2021. The patient was scheduled to receive her second injection on 08Jan2021. Since her first injection she had tested positive for COVID-19. The second dose had to be given a certain amount of days after the first. She would be outside that window. She would like to know if there is any guidance regarding the if/when she should get the second dose. The reporter would like to know if she waits longer than the recommended 21 days to receive her second dose of the COVID-19 vaccine would she need to restart the vaccination series. The reporter said this was not serious as she only had congestion and headache with treatment: using over the counter stuff. Event relatedness with COVID vaccine was unknown.; Sender's Comments: Based on available information, a possible contributory role of suspect BNT162B2 vaccine cannot be completely excluded for reported "tested positive for COVID-19".
Extreme pain in right hand and wrist right hand swollen for two days after Pfizer covid  Bivalent vaccine still wearing a hand and wrist brace and wrist is swollen and still terrible pain
Has not received his 2nd dose; Full body hives/ had hives; He was feeling itchy/ feeling fully itchy; He was really in a bad shape for 2-3 days; He had a little bad reaction to the vaccine/ "all that stuff"; Fever; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose), URTICARIA (Full body hives/ had hives), PRURITUS (He was feeling itchy/ feeling fully itchy), FEELING ABNORMAL (He was really in a bad shape for 2-3 days) and VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff") in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN and HYDROCHLOROTHIAZIDE for Blood pressure management.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced URTICARIA (Full body hives/ had hives), FEELING ABNORMAL (He was really in a bad shape for 2-3 days), VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff") and RASH (rash). March 2021, the patient experienced PRURITUS (He was feeling itchy/ feeling fully itchy) and PYREXIA (Fever). On 23-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose). In March 2021, URTICARIA (Full body hives/ had hives), PRURITUS (He was feeling itchy/ feeling fully itchy), FEELING ABNORMAL (He was really in a bad shape for 2-3 days), VACCINATION COMPLICATION (He had a little bad reaction to the vaccine/ "all that stuff"), PYREXIA (Fever) and RASH (rash) had resolved. On 23-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Has not received his 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's doctor prescribed him Prednisone but he didn't take it, as symptoms resolved in 2-3 days themselves without treatment.
The patient experience unilateral droopiness, numbness, and tingling in the face; neck and ear pain, one week after vaccine, and was rushed to ER. A diagnosis of Bells Palsy and treated with oral steroid x 6-7 days and acyclovir x 10 days.
Pfizer vaccine (ER8735) I experience intermittent heart palpitations and joint pain in my left elbow, fingers and left hip.
Painful swelling right shoulder upper third right arm post vaccination 3cm x 4cm (given on 11/16/09). Follow up on 11/23/09.